Angina market insights highlighting growth opportunities through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Angina Market Projected To Reach By 2030?

The angina market has experienced substantial growth in its size over recent years. Projections indicate its expansion from $11.36 billion in 2025 to $12.05 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. This historic growth is linked to factors such as the increasing prevalence of cardiovascular diseases, the accessibility of beta blockers and nitrates, the expansion of hospital cardiac care units, a rise in diagnostic testing, and the development of cardiology specialty care.

The angina market is projected to experience robust expansion in the coming years. It is forecast to achieve a size of $14.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This anticipated growth is driven by factors such as an increasing demand for individualized cardiovascular treatment, the expanding use of minimally invasive cardiac interventions, the growing adoption of digital cardiac monitoring, the broadening of preventive cardiology initiatives, and advances in cardiovascular drug development. Significant trends identified for the forecast period include the rising acceptance of combination drug therapies, increased application of long-acting nitrates, a concentrated focus on preventive cardiac care, the diversification of interventional treatment alternatives, and an intensified emphasis on lifestyle and risk management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Key Drivers Are Affecting The Angina Market Development?

The increasing occurrence of cardiovascular diseases is projected to stimulate the expansion of the angina market in the coming years. Cardiovascular diseases are conditions affecting the heart and blood vessels, encompassing ailments like coronary heart disease, heart failure, and stroke. The growing incidence of these diseases is primarily attributable to an aging global population and heightened exposure to preventable risk factors, including inadequate nutrition, sedentary lifestyles, and tobacco consumption. This rise in cardiovascular disease prevalence fuels the need for angina treatments, as these conditions frequently manifest as chest pain requiring medical intervention to alleviate symptoms and prevent complications. For instance, data from October 2024, sourced from the US-based Centers for Disease Control and Prevention, indicates a significant increase in cardiovascular disease deaths, climbing from 371,506 cases in 2022 to 919,032 deaths in 2023. Consequently, the escalating prevalence of cardiovascular diseases is a key factor driving the growth of the angina market.

How Is The Angina Market Segmented Across Different Segment Categories?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

What Trends Are Transforming The Angina Market?

Leading companies active in the angina market are engaged in the development of innovative pharmaceuticals, such as metoprolol tartrate tablets, aiming to deliver more efficacious and targeted therapies for individuals suffering from coronary artery disease (CAD) and related ailments. These metoprolol tartrate tablets represent a medication frequently administered for treating a range of cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, obtained final authorization from the United States Food and Drug Administration (US-FDA) to produce and offer its generic form of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol functions as a beta blocker, utilized in the management of various cardiovascular disorders, such as high blood pressure (hypertension) and chest pain (angina), and for improving survival post-heart attack.

Which Organizations Play A Role In The Angina Market Landscape?

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Get The Full Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Region Holds The Highest Market Share In The Angina Market?

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Angina Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Browse Through More Reports Similar to the Global Angina Market 2026, By The Business Research Company

Angio Suites Market Report 2026

https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795